|
See related NovoNorm tab information |
|
|
|
Manufacturer |
Novo Nordisk |
|
Distributor |
Hong Kong: DKSH/Macau: Agencia Lei Va Hong |
|
Contents |
Repaglinide |
|
Indications |
Type 2 diabetes (NIDDM).
Click to view NovoNorm detailed prescribing infomation |
|
Dosage |
Initial dose: 0.5 mg. If patients transferred from another oral antidiabetic, starting dose is 1 mg. Dosing titration by doubling the dose. Max single dose: 4 mg. Max daily dose: 16 mg.
Click to view NovoNorm detailed prescribing infomation |
|
Overdosage |
View NovoNorm overdosage for action to be taken in the event of an overdose. |
|
Administration |
Should be taken with food (Take w/in 30 min of meals.). |
|
Contraindications |
Pregnancy, lactation, Type 1 diabetes, diabetic ketoacidosis, concomitant use of gemfibrozil, childn <12 yr, severe hepatic disorders.
Click to view NovoNorm detailed prescribing infomation |
|
Special Precautions |
<18 yr old or >75 yr old. Major surgery, severe illness or infection, kidney or liver problems.
Click to view NovoNorm detailed prescribing infomation |
|
Adverse Drug Reactions |
GI disturbances, abdominal pain, diarrhoea, nausea, vomiting, constipation. Rarely, hypoglycaemia.
View ADR Monitoring Form |
|
Side Effects |
View NovoNorm side effects |
|
Drug Interactions |
Enhanced hypoglycaemic effect w/ gemfibrozil, clarithromycin, itraconazole, ketoconazole, MAOIs, nonselective β-blockers, ACE inhibitors, salicylates, octreotide, alcohol, anabolic steroids. Reduced hypoglycaemic effect w/ glucocorticoids, OCs, thiazides, danazol, thyroid hormones, sympathomimetics.
View more drug interactions with NovoNorm |
|
Pregnancy Category (US FDA) |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
Storage |
View NovoNorm storage conditions for details to ensure optimal shelf-life. |
|
Description |
View NovoNorm description for details of the chemical structure and excipients (inactive components). |
|
Mechanism of Action |
View NovoNorm mechanism of action for pharmacodynamics and pharmacokinetics details. |
|
ATC Classification |
A10BX02 - repaglinide ; Belongs to the class of other blood glucose lowering drugs excluding insulins. Used in the management of diabetes. |
|
Presentation/Packing |
|
Form |
Packing |
Photo |
|
NovoNorm tablet |
|
NovoNorm 0.5 mg x 90's |
|
NovoNorm 1 mg x 90's |
|
NovoNorm 2 mg x 90's |
|
|
|
Manufacturer: |
Novo Nordisk |
|
Distributor: |
Hong Kong: DKSH
Macau: Agencia Lei Va Hong |
|
 |
|
|
|
